Probiotic use in irritable bowel syndrome
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Over the past several years, a number of studies have addressed the role of specific strains of bacteria, or combinations thereof, to alleviate certain symptoms of irritable bowel syndrome (IBS). More importantly, the precise factors that contribute to this therapeutic effect, such as modulations in cytokine levels and alterations in colonic motility, are being clarified. This review serves to summarize the evidence for the use of probiotics in the treatment of IBS and to place this information in clinical context. Potential future developments and areas of possible research are also discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, even if the use of probiotics seems to be very promising, the very great majority of clinical trials on probiotics in IBS over the past years had methodological weaknesses, particularly due to the small number of study subjects, i.e. most often <35 per group.20,21”
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“With a prevalence of 15% to 20% in adults from Western nations, it is among the most common disease states known [ 11 ].”
BackgroundO’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“Kruis et al. [ 33 ] showed E. coli Nissle 1917 to be as efficacious as mesalamine in the maintenance of remission in ulcerative colitis.”
BackgroundSpiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155 · cited 1×
“These include increases in enterochromaffin cells, T-lymphocytes, and gut permeability [ 19 ].”
BackgroundActivation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Middleton’s Allergy: Principles and Practice
Dorward, D. A., Lucas, C. G., Allen, K. C., & Rossi, A. G. (2013) · Cited by 833
Intestinal flora in health and disease
Simon, G. L., & Gorbach, S. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90606-1 · Cited by 822
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“These factors, along with the burden of suffering that accompanies this illness, make it particularly appealing as a therapeutic target [9, 10 ].”
BackgroundEradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766 · cited 2×
“[35,36], and symbiotic preparations [ 32 ,39].”
Background
Cited by
Safety assessment of dairy microorganisms: The Lactobacillus genus
Bernardeau, M., Vernoux, J. P., Henri-Dubernet, S., & Guéguen, M. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.08.015 · Cited by 384
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365
Probiotics and Prebiotics: Effects on Diarrhea1
de Vrese, M., & Marteau, P. R. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.803s · Cited by 312
Voidarou, C., Antoniadou, Μ., Rozos, G., Tzora, A., Skoufos, I., Varzakas, T., Lagiou, A., & Bezirtzoglou, E. (2020) · Foods · doi:10.3390/foods10010069 · Cited by 281
Prebiotics and synbiotics: Recent concepts in nutrition
Mohanty, D., Misra, S., Mohapatra, S., & Sahu, P. S. (2018) · Food Bioscience · doi:10.1016/j.fbio.2018.10.008 · Cited by 206
Metadata
- Authors
- Young, P., & Cash, B. D.
- Affiliations
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Young, Patrick
- Venue
- Current Gastroenterology Reports
- Published
- 2006-07
- Volume
- 8
- Issue
- 4
- Pages
- 321-326
- ISSN
- 1522-8037 (ISSN-L)
- 1534-312X
- OpenAlex
- W2090988461
- Semantic Scholar
- 11cf1b9dc16ec3b6cfa2484d40b8d95a992504ce
- Cited by
- 22
- References
- 47
- Citations by year
- 2022: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2014: 2 · 2013: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Gastroenterology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, irritable bowel syndrome, bacterial strain, cytokines, colonic motility, probiotic therapy
- MeSH terms
- Humans, Treatment Outcome, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic use in irritable bowel syndrome. https://app.cochat.ai/papers/10.1007/s11894-006-0053-1
- The paper
- Young, P., & Cash, B. D. (2006). Probiotic use in irritable bowel syndrome. Current Gastroenterology Reports. https://doi.org/10.1007/s11894-006-0053-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.